Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
2.
Arch Osteoporos ; 16(1): 140, 2021 09 21.
Article in English | MEDLINE | ID: mdl-34546447

ABSTRACT

We reviewed exercise trials in men and women ≥ 45 years with hyperkyphosis at the baseline and performed meta-analyses for kyphosis and health-related outcomes. PURPOSE: To determine the effects of exercise interventions on kyphosis angle, back extensor muscle strength or endurance, physical functioning, quality of life, pain, falls, and adverse events in adults 45 years or older with hyperkyphosis. METHODS: Multiple databases were searched to May 2020. Randomized controlled trials (RCTs), non-RCT, and pre-post intervention studies that had at least one group with a mean kyphosis angle of at least 40° at the baseline were included. RESULTS: Twenty-four studies were included. Exercise or physical therapy improved kyphosis outcomes (SMD - 0.31; 95% confidence intervals [CI] - 0.46, - 0.16; moderate certainty evidence), back extensor muscle strength (MD 10.51 N; 95% CI 6.65, 14.38; very low certainty evidence), and endurance (MD 9.76 s; 95% CI 6.40, 13.13; low certainty evidence). Meta-analyses showed improvements in health-related quality of life (HRQoL) (SMD 0.21; 95% CI 0.06, 0.37; moderate certainty of evidence), general pain (MD - 0.26; 95% CI - 0.39, - 0.13; low certainty of evidence), and performance on the timed up and go (TUG) test (MD - 0.28 s; 95% CI - 0.48, - 0.08; very low certainty of evidence). The effects on the rate of falls (incidence rate ratio [IRR] 1.15; 95% CI 0.64, 2.05; low certainty evidence) or minor adverse events (IRR 1.29; 95% CI 0.95, 1.74; low certainty evidence) are uncertain. No serious adverse events were reported in the included studies. CONCLUSIONS: Interventions targeting hyperkyphosis may improve kyphosis outcomes in adults with hyperkyphosis.


Subject(s)
GRADE Approach , Kyphosis , Adult , Exercise , Female , Humans , Male , Muscle Strength , Quality of Life
3.
Urology ; 113: 138-145, 2018 03.
Article in English | MEDLINE | ID: mdl-29191639

ABSTRACT

OBJECTIVE: To assess the toxicity and effectiveness of contemporary metastatic castrate-resistant prostate cancer (mCRPC) treatments at a population level, among all patients in Ontario particularly treated with newer agents, including abiraterone, enzalutamide, docetaxel, and cabazitaxel. METHODS: We performed a population-based, retrospective cohort study of 2439 men aged ≥65 years treated for mCRPC with abiraterone, enzalutamide, docetaxel, or cabazitaxel from 2003 to 2015 in Ontario, Canada. Our primary outcome was treatment-related toxicity, defined as hospitalizations and emergency room (ER) visits during mCRPC treatment. Based on toxicity profiles identified during phase III trials, we further identified specific treatment-related toxicity. We calculated hazard ratios (HRs) using multivariable Cox proportional hazards models with time-varying exposures. RESULTS: Abiraterone and enzalutamide exposure were not associated with any-cause (P = .19 and .52, respectively) or treatment-related (P = .45 and .64, respectively) toxicities. In contrast, docetaxel exposure was associated with an increased risk of any-cause (HR 1.29, 95% confidence interval [CI] 1.15-1.44) and treatment-related (HR 1.52, 95% CI 1.33-1.74) toxicities. Cabazitaxel exposure was associated with a significant risk of treatment-related toxicity (HR 5.94, 95% CI 1.87-18.92) but not any-cause toxicity (HR 2.37, 95% CI 0.59-9.63). CONCLUSION: Among patients with mCRPC, we failed to show any increased risk of hospitalizations and ER visits for treatment-related complications for abiraterone or enzalutamide. In contrast, treatment with intravenous chemotherapeutic agents was associated with an increased risk of hospitalizations and ER visits to manage these complications.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Emergency Service, Hospital/statistics & numerical data , Hospitalization/statistics & numerical data , Prostatic Neoplasms, Castration-Resistant/drug therapy , Prostatic Neoplasms, Castration-Resistant/mortality , Aged , Aged, 80 and over , Androstenes/administration & dosage , Androstenes/adverse effects , Benzamides , Canada , Cohort Studies , Docetaxel/administration & dosage , Docetaxel/adverse effects , Dose-Response Relationship, Drug , Drug Administration Schedule , Humans , Kaplan-Meier Estimate , Male , Maximum Tolerated Dose , Multivariate Analysis , Nitriles , Ontario , Phenylthiohydantoin/administration & dosage , Phenylthiohydantoin/adverse effects , Phenylthiohydantoin/analogs & derivatives , Population Surveillance , Prognosis , Proportional Hazards Models , Prostatic Neoplasms, Castration-Resistant/pathology , Retrospective Studies , Risk Assessment , Survival Analysis , Taxoids/administration & dosage , Taxoids/adverse effects , Treatment Outcome
4.
AIDS Behav ; 21(12): 3457-3463, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29098454

ABSTRACT

We compared use of community and hospital-based mental health and addiction (MH&A) services by adults with and without HIV. This population-based study examined the probability and intensity of MH&A service use by individuals with (n = 5095) and without HIV (n = 2,753,091) in Ontario, Canada between 2013 and 2014. Adults with HIV were more likely than HIV-negative adults to use MH&A primary and psychiatric care, and to have MH&A emergency department visits and hospital admissions; they also used more of each service. Use of MH&A hospital services was particularly high for persons in the HIV group compared to the no HIV group.


Subject(s)
Community Mental Health Services/statistics & numerical data , HIV Infections/epidemiology , Mental Disorders/epidemiology , Mental Health , Patient Acceptance of Health Care/statistics & numerical data , Psychiatric Department, Hospital/statistics & numerical data , Adult , Cross-Sectional Studies , Emergency Service, Hospital , Female , HIV Infections/complications , HIV Infections/therapy , Humans , Male , Mental Disorders/therapy , Middle Aged , Ontario/epidemiology
5.
AIDS ; 31(5): 697-705, 2017 03 13.
Article in English | MEDLINE | ID: mdl-27922856

ABSTRACT

OBJECTIVE(S): Owing to the commonly held notion that individuals with intellectual and developmental disabilities (IDD) have low risk of HIV acquisition, we compared the prevalence of HIV infection among people with and without IDD. We also examined health status and health service use among the HIV-infected group. DESIGN: Population-based cohort study using linked administrative health and social services databases. METHODS: We compared HIV prevalence between Ontario adults with IDD (n = 64 008) and a 20% random sample of Ontario adults without IDD. Among the HIV-infected group, we compared adults with and without IDD in terms of comorbid chronic physical conditions and mental health disorders, as well as use of overall health services, mental health services, and HIV-specific services. RESULTS: HIV prevalence per 100 000 population did not differ for adults with IDD [163.38 (95% confidence interval: 132.27, 199.6)] and without IDD [172.45 (95 confidence interval: 167.48, 177.53)]. Among the HIV-infected group, those with IDD had more comorbid chronic physical conditions and mental health disorders. They also had greater use of overall health services and mental health services. Likelihood of use of HIV-specific services also differed for those with and without IDD. DISCUSSION: A similar prevalence of HIV among adults with and without IDD accentuates a need for strategies for individuals with IDD to be included in HIV prevention efforts. High prevalence of chronic physical and mental health comorbidity and health service use among the HIV-infected group with IDD highlight a need for comprehensive and coordinated treatment plans to optimize outcomes for this complex patient group.


Subject(s)
Developmental Disabilities/complications , HIV Infections/epidemiology , Health Services , Health Status , Intellectual Disability/complications , Adult , Aged , Cohort Studies , Female , HIV Infections/pathology , Humans , Male , Middle Aged , Ontario/epidemiology , Prevalence , Young Adult
6.
Can J Aging ; 35(3): 319-31, 2016 09.
Article in English | MEDLINE | ID: mdl-27426223

ABSTRACT

Few studies have focused on falls among home care (HC) clients with neurological conditions. This study identified factors that increase risk of falling among HC clients with no recent history of falls, and explored whether risk profiles varied among those with dementia or parkinsonism compared to those without selected neurological conditions. A retrospective cohort design was used and analysis of data from community-based HC clients across Ontario was conducted on a sample of ambulatory clients with dementia, parkinsonism, or none of the selected neurological conditions. Data were obtained from the Resident Assessment Instrument for HC (RAI-HC) assessment. The outcome used in multivariable analyses was whether clients fell during follow-up. Unsteady gait was a strong predictor of falls across all three groups. Co-morbid parkinsonism most strongly predicted falls in the dementia group. Clients with borderline intact to mild cognitive impairment had higher odds of falling within the parkinsonism and comparison groups.


Subject(s)
Accidental Falls/statistics & numerical data , Dementia/epidemiology , Home Care Services , Parkinson Disease/epidemiology , Accidental Falls/prevention & control , Aged , Aged, 80 and over , Arthritis/epidemiology , Cardiovascular Diseases/epidemiology , Case-Control Studies , Cognitive Dysfunction/epidemiology , Cohort Studies , Depression/epidemiology , Dizziness/epidemiology , Female , Humans , Male , Middle Aged , Odds Ratio , Ontario/epidemiology , Polypharmacy , Retrospective Studies , Risk Assessment , Vision Disorders/epidemiology
7.
Arch Phys Med Rehabil ; 95(1): 129-40, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23850611

ABSTRACT

OBJECTIVE: To evaluate previous research to determine if exercise can improve preexisting hyperkyphosis by decreasing the angle of thoracic kyphosis in adults aged ≥45 years. DATA SOURCES: PubMed, Embase, and the Cumulative Index to Nursing and Allied Health Literature databases were searched for studies related to posture, exercise, and age ≥45 years. Online conference proceedings of the American Society for Bone and Mineral Research, American Physical Therapy Association, and Gerontological Society of America were also searched. STUDY SELECTION: Two independent reviewers screened the titles and abstracts and selected studies that tested the effect of exercise on measures of kyphosis, or forward head posture, in individuals with hyperkyphosis at baseline (defined as angle of kyphosis ≥40°). Reviews, letters, notes, and non-English language studies were excluded. DATA EXTRACTION: A pilot-tested abstraction form was used by each reviewer to extract data from each study regarding details of exercise intervention, participant characteristics, safety, adherence, and results. The Cochrane Collaboration's tool for assessing risk of bias was used to assess methodologic quality. Discrepancies on the abstraction forms between the 2 reviewers were resolved by a third reviewer. A formal meta-analysis was not performed. DATA SYNTHESIS: Thirteen studies were abstracted and included in the review; of these, 8 studies saw improvements in ≥1 measure of posture. The main sources of bias were related to blinding participants and incomplete outcome data. The adherence reported across studies suggests that exercise is an acceptable intervention for individuals with age-related hyperkyphosis. CONCLUSIONS: The scarcity and quality of available data did not permit a pooled estimate of the effect of exercise on hyperkyphotic posture; however, the positive effects observed in high-quality studies suggest some benefit and support the need for an adequately designed randomized controlled trial examining the effect of exercise on hyperkyphosis.


Subject(s)
Aging/physiology , Exercise/physiology , Kyphosis/rehabilitation , Posture/physiology , Aged , Clinical Trials as Topic , Female , Humans , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...